天津赛尔生物技术有限公司成立于2004年, 是从事抗体及相关产品研发与生物技术服务的\"国家高新技术产业”，座落于天津滨海新区。我们秉承\"品质至上，追求卓越”理念不断发展壮大，经过十余年的发展，赛尔生物已经拥有一个多学科跨专业的优秀专业人员团队, 多名技术骨干均具有在海外著名科研机构学习工作的经历。现拥有研发楼和动物实验楼，具有市场优势产品研发技术体系，以及符合行业规律、以人为本并与国际接轨的高效运行管理摸式。我们专注于两大领域，服务于海外内市场。

凡是购买我公司抗体，并于2018年1月1日以后发表文章，且文章中明确标注其使用产品来源于天津赛尔生物的，可领取相应奖励。

奖励规则如下：

中文文章：50 μl抗体2支+鼠标垫1个

SCI期刊杂志：

    0

    5≤IF<10 : 200 μl抗体2支+鼠标垫1个

   10≤IF<20 : 200 μl抗体3支+鼠标垫1个

   20≤IF   : 200 μl抗体5支+鼠标垫1个

 备注： 1. 每篇文章限参与活动一次。

      2. 需提供文章全文。

公司产品发表SCI论文部分如下

Liu J, Yang C, Gu Y, et al. Knockdown of thelncRNA SNHG8 inhibits cell growth in Epstein-Barr virus-associated gastriccarcinoma[J]. Cellular & molecular biology letters, 2018, 23(1): 17.

Aishanjiang A, Rouzi N, Jiao Z, et al.MicroRNA-9 enhances invasion and migration of cervical carcinomas by directlytargeting FOXO1[J]. European review for medical and pharmacological sciences,2018, 22(8): 2253-2260.

Yu M, Wang K, Zhang H, et al.DOTAP-Incorporated PEG-PLGA Nanoparticles for Efficient In Vitro and In VivoGene Delivery[J]. Journal of Biomedical Nanotechnology, 2018, 14(2): 281-293.

Gao P, Li C, Chang Z, et al. Carcinomaassociated fibroblasts derived from oral squamous cell carcinoma promotelymphangiogenesis via c-Met/PI3K/AKT in vitro[J]. Oncology Letters, 2018,15(1): 331-337.

Li H, Wang Y, Song Y. MicroRNA-26b inhibits theimmune response to Mycobacterium tuberculosis (M. tb) infection in THP-1 cellsvia targeting TGF beta-activated kinase-1 (TAK1), a promoter of the NF-kappa Bpathway[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018,11(3): 1218-1227.

Wang Y, Fu D, Chen Y, et al. G3BP1 promotestumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis inrenal cell carcinomas[J]. Cell death & disease, 2018, 9(5): 501.

Zhao L, Zhou C, Li L, et al. Acupuncture improves cerebral microenvironment in mice with Alzheimer’s disease treated with hippocampal neural stem cells[J]. Molecular neurobiology, 2017, 54(7): 5120-5130.

Jiang C, Gong F. MiR‐148a promotes myocardial differentiation of human bone mesenchymal stromal cells via DNA methyltransferase 1 (DNMT1)[J]. Cell biology international, 2017.

Yang D, Yang Q, Wei X, et al. The role of miR-190a-5p contributes to diabetic neuropathic pain via targeting SLC17A6[J]. Journal of pain research, 2017, 10: 2395.

Bu Y, Zheng D, Wang L, et al. LncRNA TSIX promotes osteoblast apoptosis in particle-induced osteolysis by down-regulating miR-30a-5p[J]. Connective tissue research, 2017: 1-8.

Lu W Q, Hu Y Y, Lin X P, et al. Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells[J]. Oncotarget, 2017, 8(27): 44171.

Wang H, Jiang Z, Chen H, et al. MicroRNA-495 inhibits gastric cancer cell migration and invasion possibly via targeting high mobility group AT-hook 2 (HMGA2)[J]. Medical science monitor: international medical journal of experimental and clinical research, 2017, 23: 640.

Yang X, Hu Y, Liu Y, et al. C14orf28 downregulated by miR-519d contributes to oncogenicity and regulates apoptosis and EMT in colorectal cancer[J]. Molecular and cellular biochemistry, 2017, 434(1-2): 197-208.

Wang Y, Zhang R, Zhang J, et al. MicroRNA‐326‐3p ameliorates high glucose and ox‐LDL‐IC‐induced fibrotic injury in renal mesangial cells by targeting FcγRIII[J]. Nephrology, 2017.

Wang L, Wang Q T, Liu Y P, et al. ATM Signaling Pathway Is Implicated in the SMYD3-mediated Proliferation and Migration of Gastric Cancer Cells[J]. Journal of gastric cancer, 2017, 17(4): 295-305.

Ding Z, Shen X, Li Y. Association of nNOS and Rho‑kinase with age‑associated erectile dysfunction in Sprague‑Dawley rats[J]. Experimental and therapeutic medicine, 2017, 13(3): 1133-1136.

Li J, Liu B, Xue H, et al. MiR-217 has ability as the useful diagnostic biomarker and regulates human podocyte cells apoptosis via targeting TNFSF11 in membranous nephropathy[J].

Li J, Liu B, Xue H, et al. miR-217 Is a Useful Diagnostic Biomarker and Regulates Human Podocyte Cells Apoptosis via Targeting TNFSF11 in Membranous Nephropathy[J]. BioMed Research International, 2017, 2017.

Yang X, Li H, Sun H, et al. Hepatitis B virus-encoded microRNA controls viral replication[J]. Journal of virology, 2017, 91(10): e01919-16.

Chen J, Hongting L, Shaoping L, et al. MiR-34-a acts as a suppressor in neuroblastoma progression by targeting CD44[J]. JPMA. The Journal of the Pakistan Medical Association, 2017, 67(10): 1524-1531.

Zhao F, Zheng Y F, Zeng T, et al. Phosphorylation of SPOROCYTELESS/NOZZLE by the MPK3/6 kinase is required for anther development[J]. Plant physiology, 2017: pp. 01765.2016.

Yang Y, Xie Y, Wu M, et al. Expression of mmu-miR-96 in the endometrium during early pregnancy and its regulatory effects on stromal cell apoptosis via Bcl2[J]. Molecular medicine reports, 2017, 15(4): 1547-1554.

Zhu Y, Zhang Y, Sui Z, et al. USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells[J]. Oncotarget, 2017, 8(30): 48725.

Zhao X, Huang L, Xu W, et al. Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling[J]. Oncotarget, 2017, 8(41): 70130.

Zhao X, Huang L, Xu W, et al. Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling[J]. Oncotarget, 2017, 8(41): 70130.

Liu Q, Guo X, Que S, et al. LncRNA RSU1P2 contributes to tumorigenesis by acting as a ceRNA against let-7a in cervical cancer cells[J]. Oncotarget, 2017, 8(27): 43768-43781.

Cui X B, Peng H, Li R R, et al. MicroRNA-34a functions as a tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh esophageal squamous cell carcinoma[J]. Oncotarget, 2017, 8(54): 92454.